Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Stephen E. Follansbee"'
Autor:
Hans Ulrich Burger, Donna Mildvan, Martin S. Hirsch, Lucille Donatacci, M. John Gill, Stephen E. Follansbee, Douglas D. Richman, Jacob Lalezari, Richard Haubrich, Miklos Salgo, Doreen Beattie
Publikováno v:
Antiviral Therapy. 3:33-42
The objective of this randomized, double-blind, controlled multicentre study was to evaluate the efficacy of saquinavir alone or in combination with zalcitabine compared to zalcitabine monotherapy in reducing progression of human immunodeficiency vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6963f32bd701856ec1c0b300d23d1716
https://doi.org/10.1177/135965359800300103
https://doi.org/10.1177/135965359800300103
Autor:
Stephen E. Follansbee, W. Lawrence Drew, Jacob Lalezari, R C Miner, Gail I. Marousek, Susan Guentzel, Sunwen Chou, Margaret E. Poscher
Publikováno v:
The Journal of Infectious Diseases. 176:786-789
In a human immunodeficiency virus-infected subject, cytomegalovirus (CMV) isolated 9 months after the patient began oral ganciclovir prophylaxis was resistant to ganciclovir and cidofovir and contained mutations in both UL97 and Pol coding regions. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbee32e0b1f8d2e2699ea49ccd954283
https://doi.org/10.1086/517302
https://doi.org/10.1086/517302
Autor:
Stephen E. Follansbee, Dragana Jekic-McMullen, Janice A. Kolberg, Lu-Ping Shen, Jennifer Flood, Margaret E. Poscher, Janice Garve, R C Miner, W L Drew
Publikováno v:
The Journal of Infectious Diseases. 176:348-352
Branched chain DNA assay (bDNA), cytomegalovirus (CMV) antigen assay, and cerebrospinal fluid (CSF) viral culture were studied for their utility in the diagnosis of CMV polyradiculopathy and for documenting in vivo antiviral effects. CMV was demonstr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61c66ae67ec908d79da49a1d81266ad3
https://doi.org/10.1086/514051
https://doi.org/10.1086/514051
Autor:
Robert Andruczk, Jacob Lalezari, Stephen A. Spector, Mary Jean Stempien, Paula D. Sparti, Tobias Samo, George McKinley, Stephen E. Follansbee, William Buhles, Gail Simpson, Diane V. Havlir, Rodney Wong
Publikováno v:
New England Journal of Medicine. 334:1491-1497
Background In the advanced stages of the acquired immunodeficiency syndrome (AIDS), cytomegalovirus (CMV) disease, particularly vision-damaging retinitis due to CMV, is common. We evaluated prophylactic treatment with orally administered ganciclovir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e464232ceacd662192e1070c579e8688
https://doi.org/10.1056/nejm199606063342302
https://doi.org/10.1056/nejm199606063342302
Publikováno v:
Clinical Therapeutics. 18:546-558
This prospective, clinical economic study was done to determine the cost impact of oral compared with intravenous (IV) ganciclovir for the maintenance treatment of newly diagnosed cytomegalovirus (CMV) retinitis in patients with acquired immunodefici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::225d4c898813d5fc4500c2a9f2771b14
https://doi.org/10.1016/s0149-2918(96)80036-1
https://doi.org/10.1016/s0149-2918(96)80036-1
Autor:
W. Lawrence Drew, David Ives, Jacob P. Lalezari, Clyde Crumpacker, Stephen E. Follansbee, Stephen A. Spector, Constance A. Benson, Dorothy N. Friedberg, Larry Hubbard, Mary Jean Stempien, Anna Shadman, William Buhles
Publikováno v:
New England Journal of Medicine. 333:615-620
Background Cytomegalovirus retinitis, a sight-threatening infection associated with the acquired immunodeficiency syndrome (AIDS), currently requires lifelong intravenous treatment. An effective oral treatment would be an important advance. Methods W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a08b0cad83b2c303e8759da5f814392e
https://doi.org/10.1056/nejm199509073331002
https://doi.org/10.1056/nejm199509073331002
Autor:
Kathryn Squires, Barbara Mastre, W. Lawrence Drew, James D. Connor, Donald Jung, David F. Busch, Stephen E. Follansbee, Anna Shadman, Jacob Lalezari, Stephen A. Spector, William Buhles, Mark A. Jacobson
Publikováno v:
Journal of Infectious Diseases. 171:1431-1437
A phase I/II study evaluated the pharmacokinetics, tolerability, and antiviral activity of oral ganciclovir in persons infected with human immunodeficiency virus (HIV). Oral bioavailability ranged from 2.6% to 7.3%. The mean maximum serum concentrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45f4482bc316e9fa5132249a6f0f5abe
https://doi.org/10.1093/infdis/171.6.1431
https://doi.org/10.1093/infdis/171.6.1431
Autor:
John Gullett, Bernadette DeArmond, Stephen E. Follansbee, Thomas R. Matthews, William Buhles, Shelly M. Gordon, Steven G. Mehalko, William F. Owen, W. Lawrence Drew, R C Miner, David F. Busch
Publikováno v:
Journal of Infectious Diseases. 163:716-719
Seventy-two AIDS patients treated with ganciclovir for cytomegalovirus (CMV) disease were prospectively monitored for the development of drug-resistant virus. No resistant strains were found in 31 patients before therapy or among seven culture-positi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d9a8ef66678aac6317a2811f8f1e1b
https://doi.org/10.1093/infdis/163.4.716
https://doi.org/10.1093/infdis/163.4.716
Publikováno v:
Journal of Infectious Diseases. 161:1078-1084
Mucocutaneous herpes simplex virus (HSV) infections that are resistant to therapy with acyclovir have been recognized with increasing frequency in patients with the acquired immunodeficiency syndrome, although alternative therapies in this setting ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff1593803501999d3d91a46eaa1bdcb7
https://doi.org/10.1093/infdis/161.6.1078
https://doi.org/10.1093/infdis/161.6.1078